{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:12:02Z","timestamp":1777727522577,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["cstc2018jcyjAX0114"],"award-info":[{"award-number":["cstc2018jcyjAX0114"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922011"],"award-info":[{"award-number":["81922011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81861168035"],"award-info":[{"award-number":["81861168035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702088"],"award-info":[{"award-number":["81702088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871656"],"award-info":[{"award-number":["81871656"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX10202203"],"award-info":[{"award-number":["2017ZX10202203"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.virol.2021.05.007","type":"journal-article","created":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T08:01:03Z","timestamp":1621670463000},"page":"66-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Anti-HBV therapeutic potential of small molecule 3,5,6,7,3\u2032,4\u2032-Hexamethoxyflavone in vitro and in vivo"],"prefix":"10.1016","volume":"560","author":[{"given":"Ming","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9884-4716","authenticated-orcid":false,"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2021.05.007_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3748\/wjg.v13.i1.48","article-title":"Hepatitis B virus replication","volume":"13","author":"Beck","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.virol.2021.05.007_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3892\/ijo.2017.4157","article-title":"5,6,7,3',4',5'-Hexamethoxyflavone inhibits growth of triple-negative breast cancer cells via suppression of MAPK and Akt signaling pathways and arresting cell cycle","volume":"51","author":"Borah","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.virol.2021.05.007_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2020.09.019","article-title":"Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx","volume":"74","author":"Cheng","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2021.05.007_bib4","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/12081641","article-title":"Flavonoid composition of citrus juices","volume":"12","author":"Giuseppe Gattuso","year":"2007","journal-title":"Molecules"},{"key":"10.1016\/j.virol.2021.05.007_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cmet.2016.03.007","article-title":"The small molecule nobiletin targets the molecular oscillator to enhance circadian rhythms and protect against metabolic syndrome","volume":"23","author":"He","year":"2016","journal-title":"Cell Metabol."},{"key":"10.1016\/j.virol.2021.05.007_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.09.009","article-title":"(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes","volume":"111","author":"Huang","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2021.05.007_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/0929867013373723","article-title":"Biological properties of citrus flavonoids pertaining to cancer and inflammation","volume":"8","author":"John","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.virol.2021.05.007_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/hep.28916","article-title":"Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2021.05.007_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.antiviral.2008.03.006","article-title":"Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees","volume":"79","author":"Kim Sh","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2021.05.007_bib10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S1357-2725(97)00085-X","article-title":"Transcription factors: an overview","volume":"29","author":"Latchman","year":"1997","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.virol.2021.05.007_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-13-9151-4_1","article-title":"Hepatitis B virus infection: overview","volume":"1179","author":"Li H","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.virol.2021.05.007_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hep.28552","article-title":"Serum levels of hepatitis B surface antigen and DNA can predict inactive carriers with low risk of disease progression","volume":"64","author":"Liu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2021.05.007_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2017.10.014","article-title":"A novel orally available small molecule that inhibits hepatitis B virus expression","volume":"68","author":"Mueller","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2021.05.007_bib14","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.virol.2021.05.007_bib15","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2021.05.007_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jsps.2020.03.006","article-title":"Bioassay-guided isolation of anti-hepatitis B virus flavonoid myricetin-3--rhamnoside along with quercetin from leaves","volume":"28","author":"Parvez","year":"2020","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.virol.2021.05.007_bib17","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/hep.22956","article-title":"Benefits and risks of interferon therapy for hepatitis B","volume":"49","author":"Perrillo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2021.05.007_bib18","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2017.0339","article-title":"Biological sciences, Correction to 'Viral hepatitis and liver cancer","volume":"373","author":"Ringelhan","year":"2018","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.virol.2021.05.007_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2021.05.007_bib20","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1128\/JVI.00535-12","article-title":"Characterization of nucleosome positioning in hepadnaviral covalently closed circular DNA minichromosomes","volume":"86","author":"Shi","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.05.007_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/apt.15581","article-title":"Review article: clinical pharmacology of current and investigational hepatitis B virus therapies","volume":"51","author":"Smolders","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.virol.2021.05.007_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.tiv.2018.01.011","article-title":"Quercetogetin protects against cigarette smoke extract-induced apoptosis in epithelial cells by inhibiting mitophagy","volume":"48","author":"Son","year":"2018","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.virol.2021.05.007_bib23","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3892\/mmr.2020.11252","article-title":"Antiinflammatory activity of 3,5,6,7,3',4'hexamethoxyflavone via repression of the NFkappaB and MAPK signaling pathways in LPSstimulated RAW264.7 cells","volume":"22","author":"Son","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.virol.2021.05.007_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhep.2020.01.028","article-title":"Full-length 5'RACE identifies all major HBV transcripts in HBV-infected hepatocytes and patient serum","volume":"73","author":"Stadelmayer","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2021.05.007_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-0037-1606212","article-title":"Challenges to a cure for HBV infection","volume":"37","author":"Testoni","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.virol.2021.05.007_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-virology-110615-042238","article-title":"The structural biology of hepatitis B virus: form and function","volume":"3","author":"Venkatakrishnan","year":"2016","journal-title":"Annual Review of Virology"},{"key":"10.1016\/j.virol.2021.05.007_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jssc.200700331","article-title":"Validated reversed phase LC method for quantitative analysis of polymethoxyflavones in citrus peel extracts","volume":"31","author":"Wang","year":"2008","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.virol.2021.05.007_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-981-13-9151-4_2","article-title":"And biology, HBV genome and life cycle","volume":"1179","author":"Wang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.virol.2021.05.007_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.virol.2021.05.007_bib30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1080\/22221751.2019.1619485","article-title":"Robust assay for analyzing the neutralization activity of serum specimens against hepatitis B virus","volume":"8","author":"Zhang","year":"2019","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virol.2021.05.007_bib31","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.30497","article-title":"A functional variant in ubiquitin conjugating enzyme E2 L3 contributes to hepatitis B virus infection and maintains covalently closed circular DNA stability by inducing degradation of apolipoprotein B mRNA editing enzyme catalytic subunit 3A","volume":"69","author":"Zhou","year":"2019","journal-title":"Hepatology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682221001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682221001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:49:39Z","timestamp":1777459779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682221001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":31,"alternative-id":["S0042682221001112"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2021.05.007","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-HBV therapeutic potential of small molecule 3,5,6,7,3\u2032,4\u2032-Hexamethoxyflavone in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2021.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}